Salk Institute researchers found that tetrahydrocannabinol (THC) and related compounds can reduce amyloid beta proteins in human neurons. In laboratory experiments, THC promoted the cellular removal of these toxic proteins associated with Alzheimer's disease. The study showed THC not only decreased amyloid beta levels but also eliminated the inflammatory response that typically leads to neuron death.

Scientists have long known that amyloid beta accumulates in aging brain cells before Alzheimer's symptoms appear. While the exact role of these protein deposits remains unclear, they form the characteristic plaques found in patients' brains. This research suggests cannabinoids may affect both inflammation and amyloid beta accumulation in nerve cells - a finding that could offer new insights into Alzheimer's disease mechanisms and potential treatments.

The study used neurons grown in laboratory conditions to mimic aspects of Alzheimer's disease. Researchers discovered that high levels of amyloid beta trigger cellular inflammation and increased neuron death. When exposed to THC, the nerve cells showed reduced protein levels and survived longer. The findings indicate that THC-like compounds might help protect brain cells from the damage associated with Alzheimer's.